| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Chlorhexidine gluconate pink 0.5% in 70% IMS spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate 0.5% in 70% IMS solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate blue 0.5% in 70% IMS solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate pink 0.5% in 70% IMS solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate+sodium nitrite 0.5/0.1% in 70% IMS solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate 0.5% in 70% IMS surgical scrub |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ear wax removal preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorhexidine in oropharyngeal dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cetrimide and chlorhexidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorhexidine gluconate and industrial methylated spirit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical zinc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely permethrin stain 50 milligram/1 gram conventional release cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product manufactured as oropharyngeal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine- and isopropyl alcohol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate 2%/isopropyl alcohol 70% topical sponge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dental disclosing preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing erythrosin B stain (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Erythrosine 6mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate 20 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antiperspirant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing permethrin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicinal product acting as antiseborrheic agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salicylic acid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mouthwash (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Urea topical preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorhexidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical dental drug (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to keratolytics, keratoplastics and other hair treatment drugs and preparations |
Causative agent (attribute) |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rectal soothing preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Permethrin + pyethroid + piperonyl butoxide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Almond+arachis+camphor oil compound drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine digluconate+amethocaine 0.05/0.015% oral spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salicylic acid [psoriasis] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salicylic acid [acne] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salicylic acid [callosity] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicated shampoos |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Scalp applications |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Shampoos [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salicylic acid [antifungal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Soap substitutes - [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Eludril oral spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Minor skin infection preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Povidone [mouth] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Povidone mouthwash |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate 0.2% aniseed mouthwash |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely urea 400 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salicylic acid 60 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely urea 400 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate 0.6386% rinse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate 2.5mg oropharyngeal chip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate 0.12% rinse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate 1.2% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Zinc sulfate 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Zinc sulfate 25mg/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lactic acid + salicylic acid 16.7%ww/16.7%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salicylic acid gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing delmopinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Delmopinol 0.2% oral rinse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate 3.15%/isopropyl alcohol 70% topical swab |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorhexidine and chlorobutanol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing salicylic acid and sulfur (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tolnaftate+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Saliva stimulating tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorbutol+dichlorobenz+arachis oil 5%/2%/57% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salicylic acid 20% 7.5cmx4.5cm plaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salicylic acid 40% 7.5cmx4.5cm plaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine 0.5% powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorhexidine and tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorobutanol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing lauromacrogol and urea (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorhexidine and tolnaftate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing desoximetasone and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine- and phenol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing camphor and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicated toothpaste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| pâte dentifrice |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Debridement of wound with topical agent |
Using substance (attribute) |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Debridement of wound with topical agent |
Using substance (attribute) |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Topical agent allergy |
Causative agent (attribute) |
False |
agent topique |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]